PHARMACEUTICAL PREPARATIONS EMPLOYING AMINOLEVULINIC ACID

Brand Owner (click to sort) Address Description
ALA PDT DUSA PHARMACEUTICALS, INC. 29 Dunham Road Billerica MA 01887 pharmaceutical preparations employing 5-aminolevulinic acid with the exposure of light to induce a therapeutic or diagnostic effect on abnormal tissues;PDT;
ALA PDT Deprenyl USA, Inc. 378 Roncesvalles Avenue Toronto, Ontario M6R 2M7 Canada pharmaceutical preparations employing 5-aminolevulinic acid with the exposure of light to induce a therapeutic or diagnostic effect on abnormal tissues;PDT;
LEVULAN DUSA PHARMACEUTICALS, INC. 29 Dunham Road Billerica MA 01887 pharmaceutical preparations employing 5-aminolevulinic acid for use in therapy or diagnoses of malignant and non-malignant dermatologic, urologic and gynecologic tissues, lesions of the skin; conjunctiva; respiratory mucosa; digestive tract, including esophageal, gastric, duodenal, jejunal, ileal, colonic, and rectal mucosa; vaginal and cervical mucosa; endometrium; and other rapidly growing cells;
NOW'S THE TIME TO MANAGE YOUR DAMAGE DUSA PHARMACEUTICALS, INC. 29 Dunham Road Billerica MA 01887 pharmaceutical preparations employing 5-aminolevulinic acid for use in therapy of malignant and non-malignant dermatologic, lesions of the skin; including, without limitation, actinic keratoses and acne;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Therapeutic 5-aminosalicylic acid derivative compositions having general formula (I), wherein R is a 1-deoxy sugar residue or a poly(ethylene glycol) chain-containing residue, are provided. The compositions enable topical delivery of 5-aminosalicylic acid to the gastrointestinal tract following oral administration in pharmaceutical preparations. According to the invention, the compositions stabilize pharmaceutical compositions containing therapeutic 5-aminosalicylic acid derivatives in a manner that enhances the retention of said compositions in the intestine, decreases the cellular absorption thereof, and decreases the transfer of said compositions or the 5-aminosalicylic acid derived therefrom to the systemic circulation